Treatment Patterns and Costs Associated with Diffuse Large B|Cell ...

Treatment Patterns and Costs Associated with Diffuse Large B-Cell ...

Conclusions. Costs of subsequent treatments are significantly greater among those who undergo both chemotherapy and SCT ($223,338 and $185,606 for 2nd and 3rd ...

Treatment patterns and costs among US patients with diffuse large B ...

Mean medical/pharmacy costs were US$141,532 per patient per year (SD: $189,579), driven by DLBCL-related claims. Conclusion: Healthcare resource ...

Real-world treatment patterns, survival, health resource use and ...

Hospitalization was common (57%) in the 12-months after initiation of 1L treatment; the mean DLCBL-related total costs were US$84,416 during the ...

Real-World Treatment Patterns, Healthcare Resource Use, and ...

Real-world treatment patterns, healthcare resource use, and costs among patients with diffuse large B-cell lymphoma: a retrospective analysis of US claims data.

Treatment Patterns and Costs Among US Patients With Diffuse ...

In a study of patients with diffuse large B-cell lymphoma who do not proceed to transplant in second line, high HCRU and costs were mostly due to ...

Real-World Treatment Patterns, Healthcare Resource Utilization ...

Real-world treatment patterns, healthcare resource utilization, costs, and survival among Medicare beneficiaries with diffuse large B-cell lymphoma (DLBCL).

Real-World Characteristics, Treatment Patterns, Health Care ...

Patients diagnosed with diffuse large B-cell lymphoma (DLBCL) carry a substantial clinical and economic burden. A large portion of these patients require ...

Study Highlights Treatment Patterns, Costs for DLBCL Not Treated ...

New research highlights treatment patterns, health care resource utilization (HCRU), and costs associated with patients who have diffuse large B-cell lymphoma ...

Treatment patterns, healthcare resource utilization, and costs in ...

To understand treatment patterns, healthcare resource utilization (HCRU), and the economic burden of diffuse large B-cell lymphoma (DLBCL) in elderly adults in ...

A nationwide analysis of the treatment patterns, survival ... - Frontiers

Diffuse large B-cell lymphoma (DLBCL) accounts for approximately 30% of non-Hodgkin lymphoma (NHL) cases, with an age-adjusted incidence of 5.0 cases per ...

Economic burden and treatment patterns for patients with diffuse ...

The total healthcare costs were US $15,555 and $10,192 per patient per month within 1 year following their initial diagnosis for DLBCL and FL, ...

Real‐World Characteristics, Treatment Patterns, Health Care ...

Real-World Characteristics, Treatment Patterns, Health Care Resource Use, and Costs of Patients with Diffuse Large B-Cell Lymphoma in the U.S.

EE308 Real-World Treatment Patterns and Costs in Relapsed and ...

EE308 Real-World Treatment Patterns and Costs in Relapsed and Refractory Diffuse Large B-Cell Lymphoma in the United States ; A Mutebi · Genmab US, Inc, Princeton ...

Real‐World Characteristics, Treatment Patterns, Health Care ...

Diffuse large B‐cell lymphoma (DLBCL) represents the most common subtype of non‐Hodgkin lymphoma in the U.S., but current real‐world data ...

(PDF) Real‐World Characteristics, Treatment Patterns, Healthcare ...

Real‐World Characteristics, Treatment Patterns, Healthcare Resource Use and Costs of Patients with Diffuse Large B‐Cell Lymphoma in the United ...

Economic burden and treatment patterns for patients with diffuse ...

DLBCL: Diffuse large B-cell lymphoma; FL: Follicular lymphoma; SCT: Stem cell transplantation. Healthcare costs. The averages of all healthcare ...

Burden of Illness and Treatment Patterns in Second-line Large B ...

For SCT eligible patients, mean (SD) PPPM all-cause costs during the second-line treatment window were $45,981 ($50,793), and LBCL-related costs were $25,362 ($ ...

Nationwide claims database analysis of treatment patterns, costs ...

Nationwide claims database analysis of treatment patterns, costs and survival of Japanese patients with diffuse large B-cell lymphoma. Saaya ...

Economic burden and treatment patterns for patients with diffuse ...

The total healthcare costs were US $15,555 and $10,192 per patient per month within 1 year following their initial diagnosis for DLBCL and FL, respectively. The ...

Cost of Disease Progression in Diffuse Large B-cell Lymphoma After ...

To better understand the economic burden of DLBCL progression in the current treatment landscape, we conducted two independent, retrospective, ...